News | March 12, 2024
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
These approvals mark significant progress for Venus Remedies in expanding its market presence
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Subscribe To Our Newsletter & Stay Updated
